Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
Claus G Roehrborn1, Raymond C Rosen21Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA; 2New England Research Institutes, Watertown, MA, USAAbstract: Lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) are common in ag...
Guardado en:
Autores principales: | Claus G Roehrborn, Raymond C Rosen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c62a8f7c5e74916b124a7f817463211 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med
por: Zhang LT, et al.
Publicado: (2015) -
The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom
por: Yang L, et al.
Publicado: (2021) -
Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
por: Wang XY, et al.
Publicado: (2016) -
Benign prostatic hyperplasia and new treatment options – a critical appraisal of the UroLift system
por: McNicholas TA
Publicado: (2016) -
Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial
por: Amr Fawzi, et al.
Publicado: (2017)